Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Unknown 2Completed 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Advanced Solid Tumors 484Solid Tumor 446Advanced Solid Tumor 414Unspecified Adult Solid Tumor, Protocol Specific 362Solid Tumors 336Mesothelioma, Malignant 324Mesothelioma 289Solid Tumor, Adult 124Carcinoma, Non-Small-Cell Lung 122Retinoblastoma 117Lung Neoplasms 77Ovarian Neoplasms 75Melanoma 65Sarcoma 62Carcinoma, Renal Cell 59Stomach Neoplasms 58Pancreatic Neoplasms 58Neoplasms 53Esophageal Neoplasms 53Small Cell Lung Carcinoma 52Colorectal Neoplasms 52Hematopoietic and Lymphatic System Neoplasm 50Uterine Cervical Neoplasms 46Breast Neoplasms 46Solid Tumours 35Neoplasm Metastasis 35Advanced or Metastatic Solid Tumors 35Squamous Cell Carcinoma of Head and Neck 34Carcinoma, Hepatocellular 32Triple Negative Breast Neoplasms 31

Interventions

nimotuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Advanced and/or Metastatic Solid Tumours × Other solid neoplasm × Clear all
NCT05836623 2024-02-28

A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions

Crescendo Biologics Ltd.

Phase 1 Unknown
5 enrolled
Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

NCT04839991 2023-11-18

POTENTIA

Crescendo Biologics Ltd.

Phase 1 Unknown
70 enrolled
Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

NCT00369252 2007-02-28

Phase I Study of Nimotuzumab in Solid Tumours

YM BioSciences

Phase 1 Completed
18 enrolled
Other solid neoplasm

Advanced and/or Metastatic Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡